Correlation Between Edwards Lifesciences and Bone Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edwards Lifesciences and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edwards Lifesciences and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edwards Lifesciences Corp and Bone Biologics Corp, you can compare the effects of market volatilities on Edwards Lifesciences and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edwards Lifesciences with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edwards Lifesciences and Bone Biologics.

Diversification Opportunities for Edwards Lifesciences and Bone Biologics

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Edwards and Bone is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Edwards Lifesciences Corp and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Edwards Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edwards Lifesciences Corp are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Edwards Lifesciences i.e., Edwards Lifesciences and Bone Biologics go up and down completely randomly.

Pair Corralation between Edwards Lifesciences and Bone Biologics

Allowing for the 90-day total investment horizon Edwards Lifesciences Corp is expected to under-perform the Bone Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Edwards Lifesciences Corp is 4.9 times less risky than Bone Biologics. The stock trades about -0.03 of its potential returns per unit of risk. The Bone Biologics Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  158.00  in Bone Biologics Corp on September 1, 2024 and sell it today you would lose (36.00) from holding Bone Biologics Corp or give up 22.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Edwards Lifesciences Corp  vs.  Bone Biologics Corp

 Performance 
       Timeline  
Edwards Lifesciences Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Edwards Lifesciences is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Bone Biologics Corp 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Bone Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Edwards Lifesciences and Bone Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edwards Lifesciences and Bone Biologics

The main advantage of trading using opposite Edwards Lifesciences and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edwards Lifesciences position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.
The idea behind Edwards Lifesciences Corp and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world